Refine
Has Fulltext
- yes (108)
Is part of the Bibliography
- yes (108)
Year of publication
Document Type
- Journal article (108)
Keywords
- Anorganische Chemie (91)
- zwitterionic (4)
- Muscarinic receptor subtypes (3)
- Muscarinic receptors (3)
- Silicon (3)
- pentacoordinate (3)
- silicon compounds (3)
- Chemische Synthese (2)
- Difenidol (2)
- Hexahydro-sila-difenidol analogues (2)
- Muscarinic receptor antagonists (2)
- Silanol (2)
- Silicate (2)
- Stereoselectivity (2)
- crystal structure (2)
- muscarinic antagonists (2)
- muscarinic receptor subtypes (2)
- sila-substitution (2)
- toxicological properties (2)
- (4-(m-Chlorophenylcarbamoyloxy)-2-butynyl)trimethylammonium chloride/pharmacology (1)
- (Acetoxymethyl)methylphenylgermane (1)
- (Acetoxymethyl)methylphenylsilane (1)
- (Hydroxymethyl)diphenyl(piperidinoalkyl)silanes (1)
- (Methylphenylsilyl)methyl carbonates (1)
- (R)- and (S)-hexahydro- / Antimuscarinic properties / Muscarinic receptor subtypes (1)
- 04ligand (1)
- 1,4-Dioxa-2 (1)
- 29Si and 15N (1)
- 5-disila-cyclohexane ring system (1)
- AF-DX 116 (1)
- Akarizid (1)
- Anorganische Analyse (1)
- Antiseptikum (1)
- Arterioles (submucosal) (1)
- Autoradiography (1)
- Bioorganosilicon chemistry (1)
- Biotransformation (1)
- Bis[1,2-benzendiolato(2-)][(morpholinio)alkyl]silicates (1)
- Bis[1,2-benzenediolato(2-)][2-(dimethylammonio)phenyl]silicate (1)
- Bis[2,3-naphthalenediolato(2-)][(morpholinio)alkyl]silicates (1)
- Bis[2,3-naphthalenediolato(2-)][2-(dimethylammonio)phenyl]silicate (1)
- Bond cleavage (1)
- Carbachol-induced drinking (1)
- Chemie (1)
- Citrato(2-)-03 (1)
- Fluorosilicates (1)
- Ganglia (rat) (1)
- Germane (1)
- Germanium (1)
- Glucagon (1)
- Guinea-pig uterus (1)
- HT-29 colon carcinoma cells (1)
- Hexahydro-difenidol (1)
- Hexahydro-difenidol analogues (1)
- Hexahydro-procyclidine (1)
- Hexbutinol (1)
- Ileum; Atrium (1)
- Insulin (1)
- Islets of Langerhans (rat) (1)
- Kidney (perfused (1)
- Kristallstruktur (1)
- Lambda5-Germanate (1)
- Lambda5-organofluorosilicate (1)
- Lambda5Si-Spirosilicate (1)
- M4 receptors (1)
- McN-A-343 analogs (1)
- Methoctramine (1)
- Microbial reduction (1)
- Muscarinic M1 receptors (1)
- Muscarinic M1 receptors; Muscarinic M2 receptors (1)
- Muscarinic M3 receptor subtypes (1)
- Muscarinic M3selective antagonists (1)
- Muscarinic antagonist (1)
- Muscarinic receptor agonists (1)
- Muscarinic receptor antagonists (M 3-selective) (1)
- Muscarinic receptor antagonists (selective) (1)
- Muscarinic receptor subtype (1)
- Muscarinic receptor subtypes; Muscarinic rcceptor agonists (M 1-selective) (1)
- Muscarinie M2 receptors (1)
- Musearinic M4 receptors (1)
- Musearlnie M1 (1)
- Musearlnie aeetyleholine receptor agonists (1)
- Musearlnie aeetyleholine receptor antagonists (1)
- Musearlnie receptor subtypes (1)
- Olfaktorische Analyse (1)
- Oxyphencyclimine (1)
- Pentacoordinate silicon (1)
- Pharmacokinetics (1)
- Phosphatidylinositol metabolism (1)
- Pirenzepine (1)
- Pithed rat (1)
- Porcine liver esterase (1)
- Pyrrinol (1)
- Rat (1)
- Si-C I Solid-state NMR (1)
- Si-functional (1)
- Sila-biperiden (1)
- Sila-difenidol (1)
- Sila-drug (1)
- Sila-hexocyclium (1)
- Sila-pridinol (1)
- Silaanaloga (1)
- Silanes (1)
- Spirosilicate (1)
- Spirosilicates (1)
- Superior cervical ganglia (calf) (1)
- Temperaturabhängigkeit (1)
- Trihexyphenidyl (1)
- Vas deferens (1)
- Vas deferens (rabbit) (1)
- Vidcomicroscopy (1)
- X-ray (1)
- Zwitterionic (1)
- Zwitterionic [lambda]5-Spirosilicates (1)
- [3H]-Hexahydro-siladifenidol (1)
- acaricides (1)
- acetyl- (1)
- acetylcholine (1)
- animals (1)
- antihypertensive agents / pharmacology (1)
- antimuscarinic and papaverine-like activity (1)
- antimuscarinics (1)
- aorta, abdominal / drug effects (1)
- aorta, abdominal / physiology (1)
- aorta, abdominal / ultrastructure (1)
- arecoline (1)
- arecoline/analogs & derivatives (1)
- atropine (1)
- conformational anaylses (1)
- crystal and molecular structure (1)
- crystal structure of (1)
- curare-lik activity (1)
- curare-like activity (1)
- decarboxylation (1)
- diamines (1)
- dicyclidol (1)
- difenidol (1)
- dimethylphenylsilyl carbonates (1)
- enantiomers of / Muscarinic receptors (1)
- enantioselective reduction (1)
- endothelium, vascular / drug effects (1)
- endothelium, vascular / physiology (1)
- enzymatic (1)
- ethamoxytriphetol (1)
- fenbutatinoxide (1)
- hexahydro-difenidol enantiomers (1)
- hexamethonium (1)
- hexamethonium compounds (1)
- hexasila-fenbutatinoxide (1)
- hydratropyl acetate (1)
- hypolipidemic activity (1)
- indomethacin (1)
- male (1)
- microbiological transformation (1)
- muscarinic receptors (1)
- muscle contraction (1)
- muscle relaxation (1)
- norepinephrine (1)
- o-methoxy-sila-hexocyclium (1)
- optically active (1)
- p-Fluoro-hexahydro-sila-difenidol (1)
- p-fluoro-hexahydro- (1)
- parasympatholytics (1)
- pentacoordinate silicon (1)
- perfumes (1)
- pharmacological properties (1)
- piperidines (1)
- pirenzepine (1)
- rabbits (1)
- rat) (1)
- rearrangement (1)
- receptors (1)
- sila-drugs (1)
- sila-subsitution (1)
- silahexocyclium (1)
- stereoselective Transesterification (1)
- stereoselective interaction (1)
- structure (1)
- structure-activity relationships (1)
- subtypes of (1)
- syntheses (1)
- synthesis (1)
- thermal stability (1)
- triparanol (1)
- zwitterionic spirosilicate (1)
- zwitterionic λ5-Spirosilicates (1)
Institute
- Institut für Anorganische Chemie (108) (remove)
Acetyldimethylphenylsilan (2) reagiert bei Raumtemperatur mit TBAF · 3H\(_2\)O in THF bzw. mit KF in DMSO/H\(_2\)O zu [(CH\(_3\))\(_2\)SiO]\(_x\) und 1-Phenylethanol (3), welches mit praktisch quantitativer Ausbeute isoliert werden kann. Dieses Reaktionsverhalten von 2 gegenüber F\(^-\) weicht drastisch ab von dem in der Literatur beschriebenen Verhalten einiger Aroyl- und Heteroaroyltrimethylsilane. Ein Reaktionsmcchanismus, der u.a. eine 1,2-Phenylverschiebung und eine BrookUmlagerung beinhaltet, wird zur Diskussion gestellt.
Es wurden Silanale RR'R"SiOH 7 dargestellt, die Carbinolen RR'R"COH 1 (R = CH\(_3\) , R' = CH\(_3\) , CH = CH\(_2\) , C\(_2\)H\(_5\) , R" = CH\(_2\)C\(_6\)H\(_5\) , CH\(_2\)CH\(_2\)C\(_6\)H\(_5\)) mit starker Duftwirkung im Bereich blumiger Noten (Maiglöckchen-Hyazinthe-Rose) analog waren. Ihr Syntheseweg verläuft über die Reaktionsschritte (3) mit teilweise bisher unbekannten Zwischenstufen 6. Die Sila-Riechstoffe 7 sind in Intensität und Duftbereich den Carbinolen 1 ähnlich, doch ist allgemein eine Verschiebung der Duftnote von Maiglöckchen zu Hyazinthe zu beobachten.
Das Sila-Dimetacrin (3a), ein Sila-Analogon des Psychopharmakons Dimetacrin (2), und sein N,N-Diethylderivat 3 b sowie sein 3-Chlorderivat 3 c wurden, von den o-Halogenanilinen 4 a- c ausgehend, über die teilweise unbekannten Stufen 5 a- c bis 10a- d synthetisiert, in ihren Eigenschaften beschrieben und in ihrer Struktur über Elementaranalysen, \(^1\)H-NMR- und Massenspektren sichergestellt. Die Synthese des Zwischenproduktes Bis(2-bromphenyl)amin (9a) konnte optimiert werden.
l In an attempt to assess the structural requirements for the musearlnie receptor selectivity of hexahydro-diphenidol (hexahydro-difenidol) and hexahydro-sila-diphenidol (hexahydro-sila-difenidol), a serles of structurally related C/Si pairs were investigated, along with atropine, pirenzepine and methoctramine, for their binding affinities in NB-OK 1 cells as well as in rat heart and pancreas. 2 The action of these antagonists at musearlnie receptors mediating negative inotropic responses in guinea-pig atrla and ileal contractions has also been assessed. 3 Antagonist binding data indicated that NB-OK 1 cells (M\(_1\) type) as weil as rat heart (cardiac type) and pancreas (glandularjsmooth muscle type) possess different muscarinic receptor subtypes. 4 A highly significant correlation was found between the binding affinities of the antagonists to muscarinic receptors in rat heart and pancreas, respectively, and the affinities to muscarinic receptors in guinea-pig atria and ileum. This implies that the musearlnie binding sites in rat heart and the receptors in guinea-pig atrla are essentially similar, but different from those in pancreas and ileum. 5 The antimuscarinic potency of hexahydro-diphenidol and hexahydro-sila-diphenidol at the three subtypes was inftuenced differently by structural modifications (e.g. quaternization). Different selectivity profiles for the antagonists were obtained, which makes these compounds useful tools to investigate further muscarinic receptor heterogeneity. lndeed, the tertiary analogues hexahydrodiphenidol (HHD) and hexahydro-sila-diphenidol (HHSiD) bad an M\(_1\) = glandularjsmooth muscle > cardiac selectivity profile, whereas the quaternary analogues HHD methiodide and HHSiD methiodide were M\(_1\) preferring (M\(_1\) > glandularjsmooth muscle, cardiac).
Wc invcstigatcd thc binding properlies of thc (R)- and (Sl-cnantiomcrs of thc muscarinic antagonists trihcxyphcnidyl, procyclidinc, hcxahydro-difcnidol. p-fluoro-hcxahydro-difcnidol. hcxbutinol, p-fluoro-hcxbutinnl. and thcir corrcsponding methiodidcs at muscarinic M\(_1\), M\(_2\)• M\(_3\) and M\(_4\) receptor subtypes. In addition. binding properlies of thc (R)- and (S)-cnantiomcrs of oxyphcncycliminc wcrc studicd. The {R)- cnantiomcrs (cutomcrs} of all the compounds had a grcatcr affinity than the (S)-isomcrs for thc four muscarinic rcccptor subtypcs. Thc binding pattcrns of thc (R)- and (S)-enantiomers wcrc gcncrally different. We did not obscrvc any gcncral corrclation hctwccn thc potcncy of thc high-affinity enantiomer and Lhc affinity ratio (cudismic ratio) of the two cnantiomcrs. Thc rcsuhs arc discusscd in tcrms of a 'four suhsitcs' binding modcl.
Hexahydro-sila-difenidoJ and eight analogues behaved as simple cumpetitive inhibitors of eHJN·methyl·scopoJamine binding to homogenates frorn human neuroblastoma NB-OK 1 cells (M\(_1\) sites), rat heart (M\(_2\) sites), rat pancreas (M\(_3\) sites), and rat striatum 'B' sites (M\(_4\) sites). Pyrrolidino- and hexamethyleneimino analogues showed the same sekctivity profile as the parent compound. Hexahydro-sila-difenidol methiodide and the methiodide of p-fluoro-hexahydro·sila-difenidol had a fügher affinity but a lower selectivity than the tertiary amines. Compounds containing a p·methoxy, p-chJoro or p-fluoro substituent in the phenyl ring of hexahydro-sila-difenidol showed a qualitative)y similar selectivity profile as the parent compound (i.e., M\(_1\)= M\(_3\) = M\(_4\) >M\(_2\) ), but up to 16-fold lower affinities. o-Methoxy-hexahydro-sila-difenidol has a lower affinity than hexahydro-sila-difeni.:!o! at the four binding sites. lts selectivity profile (M\(_4\) > M\(_1\), M\(_3\) > M\(_2\) ) was different from hexahydro-sila-difenidol. Replacement of the centrat silicon atom of hexahydro-sila-difenidol, p-fluoro-hexahydro-sila-difenidol and thdr quatemary (N-methylated) analogues by a carbon atom did not change their binding affinities significantly. The iour muscarinic receptors showed a higher affinity for the (R)- than for the (S)-enantiomers of hexahydro-difenidol, p-fluorohexahydro-difenidol and their methiodides. The stereoselectivity varied depending on the receptor subtype and drug considered.
(R)-Hexahydro-difenidol has a higher affinity for M\(_1\) receptors in NB-OK 1 cells, pancreas M\(_3\) and striatum M\(_4\) receptors (pKi 7.9 to 8.3) than for cardiac M2 receptors (pKi 7 .0). (8)-Hexahydro-difenidol, by contrast, is nonselective (pKi 5.8 to 6.1). Our goal in the present study was to evaluate the importance ofthe hydrophobic phenyl, and cyclohexyl rings of hexahydro-difenidol for the stereoselectivity and reeeptor selectivity of hexahydro-difenidol binding to the four muscarinic receptors. Our results indieated that replacement of the phenyl ring of hexahydro-difenidol by a cyclohexyl group <~ dicyclidol) and ofthe cyclohexyl ring by a phenyl moiety <~ difenidol) indueed a !arge (4- to 80-fold) decrease in binding affinity for all musearlnie receptors. Difenidol had a signifieant preference for M\(_1\) , M\(_3\) , and M\(_4\) over M\(_2\) receptors; dicyclidol, by eontrast, had a greater affinity for M\(_1\) and M\(_4\) than for M\(_2\) and M\(_3\) receptors. The binding free energy deerease due to replacement ofthe phenyl and the cyelohexyl groups of(R)-hexahydro-difenidol by, respectively, a eyclohexyl and a phenyl moiety was almostadditive in the ease of M\(_4\) (striatum) binding sites. In the ease ofthe cardiac M\(_2\), pancreatic M\(_3\) , or NB-OK 1 M\(_1\) receptors the respective binding free energies were not eompletely additive. These results suggest that the four (R)-hexahydro-difenidol ''binding moieties" (phenyl, cyclohexyl, hydroxy, and protonated amino group) cannot simultaneously form optimal interaetions with the M\(_1\), M\(_2\), and M\(_3\) muscarinic receptors. When eaeh of the hydrophobic groups is modified, the position of the whole molecule, relative to the four subsites, was changed to allow an optimal overall interaction with the musearlnie receptor.
The goals of the present study were: (1) to investigate thc binding properlies oi (R)- and (S)-procyclidine and two aehiral derivatives of muscarinic M\(_1\)• M\(_2\) and M\(_4\) receptor subtypes and (2) to identify the interaetions which allow these receptors to diseriminate between the two stereoisomers. (R)-Procyclidine showed a higher affinity for human neuroblastoma NB-OK 1 muscarinie M\(_1\) and rat striatum musearinie M\(_4\) receptors. a~ compared to rat cardiac M\(_2\) receptors. (S)-Procyclidine had a 130-iold lower affinity than (R)-procyclidine for M\(_1\) and M\(_4\) receptors. and a 40-fold lower affinity for M\(_2\) receptors. Pyrrinol. the aehiral diphenyl derivative with the eyclohexyl g.roup of (S}-procyclidine replaeed by a phenyl group, has an eight-fold lower affinity for M\(_1\) and M\(_4\) receptors. as eompared to (R)-procyclidine, and a three-fold lower affinity for M\(_2\) receptors. Hexahydro-procyclidine. the eorresponding achiral dicyclohexyl compound, had a 10- to 20-fold lower affinity than (R)-procyclidine for the three reeeptors. The inerease in binding free energy, which is observed when the phenyl and eyclohexyl groups of procyelidine are separately replaeed by cyclohexyJ and phenyl groups, respectively. was additive in the ease of M\(_1\)• M\(_2\) and M\(_4\) receptcrs. This indicates that the musearinic reeeptor s!ereoseleetivity was based on the eoexistence of two binding sites, one preferring a phenylrather than eyclohexyl group and the seeond preferring a cyclohexyl rather than a phenyl group. In addition. there were aiso binding sites for the hydroxy moiety and the protonated amino group of the ligands. The greater affinity and stereoselectivity of M\(_1\) and M\(_4\) muscarinic receptors for (R)-procyelidine reflected the better fit of the eyclohexyl group of (R)-procyclidine to the subsite of M\(_1\) and M\(_4\) as compared to M\(_2\) receptors.
Cholinergie agents arepotent modulators of insulin release that aet via musearinie reeeptors. We now investigated the muscarinic receptor subtype present in rat panereatic islets in binding and funetional studies. Binding of 5 nM [ \(^3\)H]N-methylscopolamine ([\(^3\)H]NMS) was half maximal at 30 min. At 60 min, the maximal total bindingwas 1.29% and the non-specifie binding (presence of 100 ,uM atropine) was 0.18% of the total radioaetivity per 10 f.'g islet protein. Unlabelled atropine inhibited [\(^3\)H]NMS binding with an IC50 of ca. 30 nM. The rank order of antagonist high-affinity binding was atropine > sila-hexocyelium methyl sulfate (SiHC; M\(_1\) > M\(_3\) > M\(_2\) ) > pirenzepine (M\(_1\)> M\(_2\) = M\(_3\) ) = methoctramine (M\(_2\) > M\(_1\) > M\(_3\) ). The high-affinity K\(_d\)s were 8.5, 56, 1300 and 1300 nM, respectively. The high affinity Kd of the muscarinie receptor agonist, arecaidine propargyl ester (APE), was 8.1 nM. The EC\(_{50}\) for the biologieal effects of APE on insulin and glucagon secretion was 3.2 and 2.3 nM. The rank order for the high-affinity biological effects of antagonists (inhibition of APE-mediated insulin/ glucagon release) was almost the same as for binding. The data indicate that rat pancreatie islets contain neither an M\(_1\) subtype (high-affinity for pirenzepine) nor an M\(_2\) subtype (high-affinity for methoctramine) receptor. However, the data evidence an M\(_3\) receptor subtype, since SiHC in the absence of the M\(_1\) receptor subtype shows a relatively high affinity to the receptors in rat panereatic islets.
Die Umsetzung von Diphenyl-vinylsilan mit zyklischen sekundären Aminen (z.B. Morpholin) in Gegenwart der entsprechenden Lithium-amide führt zu einer Substitution des an Silicium gebundenen H-Atoms durch eine Aminogruppe und zu einer Addition des Amins an die Vinylgruppe. 2-Thienylphenyl- vinylsilan reagiert jedoch zusätzlich unter Spaltung der Si-e-Bindung und Aminosubstitution der 2-Thienylgruppe.